ATE327238T1 - Pkb-3564-substanz mit die gefässneubildung hemmender wirkung - Google Patents

Pkb-3564-substanz mit die gefässneubildung hemmender wirkung

Info

Publication number
ATE327238T1
ATE327238T1 AT02722751T AT02722751T ATE327238T1 AT E327238 T1 ATE327238 T1 AT E327238T1 AT 02722751 T AT02722751 T AT 02722751T AT 02722751 T AT02722751 T AT 02722751T AT E327238 T1 ATE327238 T1 AT E327238T1
Authority
AT
Austria
Prior art keywords
group
hydrogen atom
represents hydrogen
combine together
pkb
Prior art date
Application number
AT02722751T
Other languages
English (en)
Inventor
Hiroyuki Osada
Hideaki Kakeya
Hiroshi Konno
Susumu Kanazawa
Original Assignee
Riken
Inst Of Biotechnology Applied
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riken, Inst Of Biotechnology Applied filed Critical Riken
Application granted granted Critical
Publication of ATE327238T1 publication Critical patent/ATE327238T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
AT02722751T 2001-04-25 2002-04-24 Pkb-3564-substanz mit die gefässneubildung hemmender wirkung ATE327238T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001127576A JP2002322182A (ja) 2001-04-25 2001-04-25 血管新生阻害作用を有するｒｋｂ−３５６４物質

Publications (1)

Publication Number Publication Date
ATE327238T1 true ATE327238T1 (de) 2006-06-15

Family

ID=18976422

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02722751T ATE327238T1 (de) 2001-04-25 2002-04-24 Pkb-3564-substanz mit die gefässneubildung hemmender wirkung

Country Status (8)

Country Link
US (1) US7094802B2 (de)
EP (1) EP1389619B1 (de)
JP (1) JP2002322182A (de)
KR (1) KR20040002925A (de)
AT (1) ATE327238T1 (de)
CA (1) CA2445376A1 (de)
DE (1) DE60211686D1 (de)
WO (1) WO2002088137A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7424026B2 (en) * 2004-04-28 2008-09-09 Nokia Corporation Method and apparatus providing continuous adaptive control of voice packet buffer at receiver terminal
JP4617136B2 (ja) * 2004-11-02 2011-01-19 学校法人東京理科大学 新規化合物、これを含有する医薬及びこの製造方法
KR101039520B1 (ko) * 2008-09-08 2011-06-09 서울대학교산학협력단 테고합판 표판 및 이판 대체재용 함침 라이너지 및 이를 적용한 테고합판

Also Published As

Publication number Publication date
KR20040002925A (ko) 2004-01-07
EP1389619A1 (de) 2004-02-18
EP1389619B1 (de) 2006-05-24
WO2002088137A1 (en) 2002-11-07
DE60211686D1 (de) 2006-06-29
EP1389619A4 (de) 2004-07-14
CA2445376A1 (en) 2002-11-07
US20050033066A1 (en) 2005-02-10
JP2002322182A (ja) 2002-11-08
US7094802B2 (en) 2006-08-22
WO2002088137A9 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
NO950297D0 (no) Prolinamidderivater
NO324249B1 (no) Glykopyranosyloksybenzylbenzenderivater, medisinske sammensetninger inneholdende slike, samt intermediater til fremstilling av derivatene
EP1426365A4 (de) 3-phenoxy-4-pyridazinolderivat und dieses enthaltende herbizide zusammensetzung
DE69331414D1 (de) Depsipeptide, herstellung und anwendung
EP1312601A4 (de) Carbonsäurederivate, verfahren zu deren herstellung und medikamente, die diese als wirkstoff enthalten
CA2336412A1 (en) Medicament for treatment of diabetes
EP1300399A4 (de) Phenylpyridazinderivate und diese enthaltende arzneimittel
ATE311367T1 (de) 5-substituierte alkylaminopyrazol-derivative als pestizide
EP1634874A4 (de) Imidazolidinderivate
DE60008218D1 (de) Heterozyklische verbindungen, ihre zwischenprodukte und elastase-inhibitoren
EA200100916A1 (ru) Лекарственное средство, содержащее производное сульфопиранозилацилглицерина
ATE525366T1 (de) Benzoxazolderivate und pharmazeutische zubereitungen die diese enthalten
ATE365158T1 (de) Pyrimidincarbonsäurederivate
YU33202A (sh) Jedinjenja o-etar oksima i fungicidi za primenu u zemljoradnji i vrtlarstvu
EP1156039A4 (de) Pyridazin-3-on-derivate und sie enthaltende medikamente
ATE327238T1 (de) Pkb-3564-substanz mit die gefässneubildung hemmender wirkung
NO20070421L (no) Radiosensitiviserende middel
EP0605728A4 (de) Chromonderivate und diese als aktivbestandteile enthaltende aldose reduktase-inhibitoren.
ATE275560T1 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
FR2781155B1 (fr) Medicaments contenant des derives de polyhydroxyalkylpyrazine, les nouveaux derives de polyhydroxyalkylpyrazine et leur preparation
ATE262522T1 (de) Benzimidazolverbindungen
KR970021070A (ko) 신규 퓨라논 유도체
ATE404548T1 (de) Cyclisches hemiacetalderivat und dessen anwendung
TH63479A (th) สารประกอบเฮเทอโรไซคลิกใหม่ และการใช้ทางเภสัชกรรมของสารประกอบ
TH19860A (th) สารประกอบเอสเทอร์และสารควบคุมสิ่งมีชีวิตที่เป็นอันตราย ซึ่งมีสารประกอบเอสเทอร์นี้เป็นส่วนประกอบที่แสดงฤทธิ์

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties